BDX
Becton Dickinson and Company
NYSE: BDX · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$145.31
-2.82% today
Updated 2026-04-29
Market cap
$41.34B
P/E ratio
23.74
P/S ratio
1.89x
EPS (TTM)
$6.12
Dividend yield
2.79%
52W range
$125 – $186
Volume
2.7M
Becton Dickinson and Company (BDX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.08B | $1.24B | $1.69B | $1.72B | $1.74B | $1.72B | $1.76B | $1.51B | $1.74B | $1.73B | $2.56B | $2.55B | $2.87B | $3.33B | $3.54B | $4.65B | $2.63B | $2.99B | $3.80B | $3.43B |
| Capital expenditures | $482.10M | $578.73M | $651.29M | $700.69M | $632.47M | $605.26M | $553.64M | $588.00M | $653.00M | $633.00M | $718.00M | $727.00M | $895.00M | $957.00M | $810.00M | $1.23B | $973.00M | $874.00M | $725.00M | $760.00M |
| Depreciation | $405.10M | $441.34M | $477.42M | $470.19M | $502.11M | $504.09M | $510.94M | $546.00M | $562.00M | $891.00M | $1.11B | $1.09B | $1.98B | $2.25B | $2.15B | $2.27B | $2.23B | $2.29B | $2.29B | $2.46B |
| Stock-based comp | $96.03M | $82.72M | $100.58M | $86.57M | $79.37M | $73.36M | $89.05M | $100.00M | $113.00M | $166.00M | $196.00M | $174.00M | $322.00M | $261.00M | $244.00M | $237.00M | $233.00M | $259.00M | $247.00M | $258.00M |
| Free cash flow | $594.30M | $661.71M | $1.04B | $1.02B | $1.11B | $1.11B | $1.21B | $919.00M | $1.09B | $1.10B | $1.84B | $1.82B | $1.97B | $2.37B | $2.73B | $3.42B | $1.66B | $2.12B | $3.07B | $2.67B |
| Investing cash flow | $-786.53M | $-1.02B | $-783.02M | $-1.07B | $-705.63M | $-1.04B | $-900.11M | $-523.00M | $-948.00M | $-8.32B | $-669.00M | $-883.00M | $-15.83B | $-741.00M | $-1.23B | $-1.88B | $-3.22B | $-716.00M | $-5.51B | $-818.00M |
| Financing cash flow | $-342.17M | $-726.03M | $-585.83M | $-79.70M | $-1.22B | $-714.38M | $-370.17M | $-968.00M | $-807.00M | $6.19B | $-1.76B | $10.98B | $-57.00M | $-3.22B | $22.00M | $-3.31B | $-591.00M | $-1.96B | $2.09B | $-3.62B |
| Dividends paid | $212.43M | $239.81M | $278.51M | $316.88M | $345.71M | $361.20M | $367.61M | $386.00M | $421.00M | $485.00M | $562.00M | $677.00M | $927.00M | $984.00M | $1.03B | $1.05B | $1.08B | $1.11B | $1.10B | $1.20B |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $-40.71M | — | $219.00M | $-29.00M | — | $117.00M | $12.64B | $-13.04B | — | $2.33B | $-539.00M | $-1.49B | — | — | — |